LGD-3303 Poeder, 1gr MK-777 Mice with an ovariectomy had

Mice with an ovariectomy had more bone trabeculae in the femur and tibia after supplementation

there is a solution of 20 mg/ml

uitleg hieronder

Volgens Zhang et al

LGD-3303 Poeder, 1gr MK-777 Mice with an ovariectomy hadLGD 3303 What is LGD 3303? The company Ligand Pharmaceuticals originally developed the lead compound LGD 4033. In 2007, they synthesized a derivative called 9 Chloro 2 ethyl 1 methyl 3 (2,2,2 trifluoroethyl) 3H pyrrolo[3,2 f]quinoline 7(6H) one, better known as LGD 3303. This SARM, which is commercially available, is an orally administered, non steroidal compound. Early studies with animal models have shown that it can increase bone mineral density